FDA Panel Urges Rejection of Jaundice Drug for Newborns FDA Panel Urges Rejection of Jaundice Drug for Newborns

An FDA panel suggests further study of stannsoporfin as a hyperbilirubinemia treatment for newborns. The experimental drug has passed through several organizations since the late 1980s.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pediatrics News Source Type: news
More News: Health | Jaundice | Pediatrics | Study